Suppr超能文献

口服制剂中甾体药物的掩味

Taste Masking of Steroids for Oral Formulations.

作者信息

Ahmed Kawther Khalid, Kassab Hanan Jalal, Al Ramahi Intesar Jawad, Alwan Zahraa Salim

机构信息

University of Baghdad, College of Pharmacy, Department of Pharmaceutics, Baghdad, Iraq.

Avi Sina Center for Pharmaceutical Research, Corporation of Research and Industry Development, Baghdad, Iraq.

出版信息

Turk J Pharm Sci. 2024 Jan 19;20(6):352-360. doi: 10.4274/tjps.galenos.2023.24968.

Abstract

OBJECTIVES

Oral steroids are commonly prescribed to children. Steroids have a strong bitter taste that limits their oral acceptance in children. The objective of this study was to formulate a pediatric-friendly and palatable oral dosage form of steroids.

MATERIALS AND METHODS

Solid dispersions of dexamethasone were prepared using polyethylene glycol, pectin, and Eudragit as carrier polymers, and chocolate as a flavoring agent. Taste masking efficiency was evaluated by healthy volunteers to select the best formula. The selected formula was pressed into chewable tablets with varying amounts of sweeteners. Chewable tablets were evaluated for palatability, hardness, and chewing index. The typical application of the taste masking approach was confirmed using prednisolone.

RESULTS

Eudragit-based solid dispersions were effective in dexamethasone taste masking. Using 40% mannitol resulted in palatable tablets with acceptable hardness and chewing difficulty. The effectiveness of the taste masking approach was successfully used to prepare prednisolone chewable tablets. However, an increase in the carrier: drug ratio and a change in the flavor to pineapple were necessary to achieve maximum palatability of prednisolone chewable tablets.

CONCLUSION

Eudragit solid dispersion is an effective method for the taste masking highly bitter steroids. The solid dispersion was successfully pressed into a palatable, easy-to-chew, and pediatric-friendly chewable tablet dosage form. The carrier: drug ratio and the choice of flavoring agent are crucial factors in improving tablet palatability.

摘要

目的

口服类固醇药物常用于儿童。类固醇具有强烈的苦味,这限制了儿童对其口服的接受度。本研究的目的是研制一种对儿童友好且口感良好的类固醇口服剂型。

材料与方法

以聚乙二醇、果胶和丙烯酸树脂为载体聚合物,巧克力为调味剂,制备地塞米松固体分散体。通过健康志愿者评估掩味效果以选择最佳配方。将所选配方压制成含有不同量甜味剂的咀嚼片。对咀嚼片的口感、硬度和咀嚼指数进行评估。使用泼尼松龙证实了掩味方法的典型应用。

结果

基于丙烯酸树脂的固体分散体对地塞米松有有效的掩味作用。使用40%的甘露醇可得到口感良好、硬度和咀嚼难度可接受的片剂。掩味方法的有效性成功用于制备泼尼松龙咀嚼片。然而,为了使泼尼松龙咀嚼片达到最大的适口性,需要提高载体与药物的比例并将调味剂改为菠萝味。

结论

丙烯酸树脂固体分散体是一种有效掩蔽高苦味类固醇药物的方法。该固体分散体成功压制成口感良好、易于咀嚼且对儿童友好的咀嚼片剂型。载体与药物的比例和调味剂的选择是提高片剂适口性的关键因素。

相似文献

1
Taste Masking of Steroids for Oral Formulations.口服制剂中甾体药物的掩味
Turk J Pharm Sci. 2024 Jan 19;20(6):352-360. doi: 10.4274/tjps.galenos.2023.24968.
9
Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.酮洛芬速溶片的处方设计与体外评价
Pharm Dev Technol. 2016 Dec;21(8):901-908. doi: 10.3109/10837450.2015.1022792. Epub 2015 Mar 23.
10
Orodispersible films and tablets with prednisolone microparticles.含泼尼松龙微粒的口腔崩解膜和片剂。
Eur J Pharm Sci. 2015 Jul 30;75:81-90. doi: 10.1016/j.ejps.2015.04.006. Epub 2015 Apr 16.

本文引用的文献

2
Paediatric specific dosage forms: Patient and formulation considerations.儿科专用剂型:患者和剂型考虑因素。
Int J Pharm. 2022 Mar 25;616:121501. doi: 10.1016/j.ijpharm.2022.121501. Epub 2022 Jan 29.
4
Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.药物非晶态固体分散体:制备策略综述
Acta Pharm Sin B. 2021 Aug;11(8):2505-2536. doi: 10.1016/j.apsb.2021.05.014. Epub 2021 Jun 5.
7
Patent landscape of pediatric-friendly oral dosage forms and administration devices.儿科口服剂型和给药装置的专利全景。
Expert Opin Ther Pat. 2021 Jul;31(7):663-686. doi: 10.1080/13543776.2021.1893691. Epub 2021 Apr 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验